JNJ - Beating COVID-19 With The Pacer BioThreat Strategy ETF (Podcast Transcript)
- Rushed to market just 6 months into the COVID-19 pandemic, the Pacer BioThreat Strategy ETF (VIRS) takes a unique approach to picking potential pandemic winners.
- The LifeSci BioThreat Strategy Index underlying VIRS selects holdings based on seven different criteria - everything from potential vaccine makers to companies powering the transition to a work-from-home economy.
- Pacer ETFs President Sean O’Hara joins the podcast to explain why his firm's newest fund is designed to protect investor portfolios from pandemics, both present and future.
- This article includes a full transcript of the podcast that was posted last week.
For further details see:
Beating COVID-19 With The Pacer BioThreat Strategy ETF (Podcast Transcript)